Prosecution Insights
Last updated: November 04, 2026
Application No. 18/021,987

BIOMASS MEASURING SYSTEM FOR FIXED BED BIOREACTOR AND RELATED METHODS

Non-Final OA §102§103§112
Filed
Feb 17, 2023
Priority
Aug 21, 2020 — provisional 63/068,669 +1 more
Examiner
HENKEL, DANIELLE B
Art Unit
1796
Tech Center
1700 — Chemical & Materials Engineering
Assignee
UNIVERCELLS TECHNOLOGIES SA
OA Round
3 (Non-Final)
56%
Grant Probability
Moderate
3-4
OA Rounds
0m
Est. Remaining
80%
With Interview

Examiner Intelligence

Grants 56% of resolved cases
56%
Career Allowance Rate
368 granted / 653 resolved
-8.6% vs TC avg
Strong +23% interview lift
Without
With
+23.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 8m
Avg Prosecution
27 currently pending
Career history
678
Total Applications
across all art units

Statute-Specific Performance

§101
0.4%
-39.6% vs TC avg
§103
55.5%
+15.5% vs TC avg
§102
16.7%
-23.3% vs TC avg
§112
17.6%
-22.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 653 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 7/29/26 has been entered. Claims 1-2, 4-10, 49, 54, 55, 59-66 are pending, of which claims 4-10 were previously withdrawn and claims 60-66 are new. The previous claim objections and 35 USC 112 claim rejections have been withdrawn due to the amendment. Election/Restrictions Newly submitted claims 62-66 are directed to an invention that lacks unity with the invention originally claimed for the following reasons: they do not relate to a single general inventive concept under PCT Rule 13.1 because, under PCT Rule 13.2, they lack the same or corresponding special technical features for the following reasons: even though the inventions of these groups require the technical feature of a bioreactor including a fixed bed; a sensor system for sensing a cell density comprising at least one of the following: a sensor for measuring impedance, the sensor comprises a pair of electrodes arranged with the fixed bed positioned therebetween, this technical feature is not a special technical feature as it does not make a contribution over the prior art in view of CASTILLO (GB2465282) as previously cited. CASTILLO discloses a culture device with a fixed bed bioreactor (page 2, lines 23-24)(an apparatus for culturing cells comprising a bioreactor including a fixed bed for culturing cells); a sensor containing an electrode arrangement to measure culture parameters especially biomass (cell density)(page 6, lines 18-20)(a sensor system for sensing a cell density); the cell density is determined by electrical impedance analysis (page 6, lines 25-26)(a sensor for measuring impedance across at least a portion of the fixed bed); Castillo further teaches the electrical impedance analysis is done using an electrode arrangement of at least four measuring electrodes (pair of electrodes)(page 6, lines 26-28) and as seen in Fig. 7, the sensor element containing the electrodes are arranged with a portion of the fixed bed positioned between. Therefore, the shared technical features lack novelty and does not make a contribution over the prior art and does not constitute a special technical feature. Since applicant has received an action on the merits for the originally presented invention, this invention has been constructively elected by original presentation for prosecution on the merits. Accordingly, claims 62-66 are withdrawn from consideration as being directed to a nonelected invention. See 37 CFR 1.142(b) and MPEP § 821.03. To preserve a right to petition, the reply to this action must distinctly and specifically point out supposed errors in the restriction requirement. Otherwise, the election shall be treated as a final election without traverse. Traversal must be timely. Failure to timely traverse the requirement will result in the loss of right to petition under 37 CFR 1.144. If claims are subsequently added, applicant must indicate which of the subsequently added claims are readable upon the elected invention. Should applicant traverse on the ground that the inventions are not patentably distinct, applicant should submit evidence or identify such evidence now of record showing the inventions to be obvious variants or clearly admit on the record that this is the case. In either instance, if the examiner finds one of the inventions unpatentable over the prior art, the evidence or admission may be used in a rejection under 35 U.S.C. 103 or pre-AIA 35 U.S.C. 103(a) of the other invention. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 61 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 61 recites “at least one electrode of the pair of electrodes is located between layers of the fixed bed”, however there is no antecedent basis for the limitation of “layers of the fixed bed”. Therefore, it is unclear if this limitation is intended to be a further limiting positive recitation of an additional feature of the fixed bed or if the limitation is intended to only apply in an instance where layers happen to be present and therefore is not further limiting of the currently claimed invention. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1-2, 49, 54-55, 60 is/are rejected under 35 U.S.C. 102a1 as being anticipated by CASTILLO (GB2465282). Regarding claim 1, Castillo teaches the following: A culture device with a fixed bed bioreactor (page 2, lines 23-24)(an apparatus for culturing cells comprising a bioreactor including a fixed bed for culturing cells); A sensor containing an electrode arrangement to measure culture parameters especially biomass (cell density)(page 6, lines 18-20)(a sensor system for sensing a cell density of at least a portion of the fixed bed); The cell density is determined by electrical impedance analysis (page 6, lines 25-26)(a sensor for measuring impedance across at least a portion of the fixed bed); The electrical impedance analysis is done using an electrode arrangement of at least four measuring electrodes (pair of electrodes)(page 6, lines 26-28) and as seen in Fig. 7, below, the sensor element containing the pair of electrodes that are arranged at different locations within the cell culture area and arranged with a portion of the fixed bed positioned between (page 27, lines 5-9). Note: Castillo teaches the particular features, structures or characteristics may be combined in any suitable manner in one or more embodiments. PNG media_image1.png 290 331 media_image1.png Greyscale Regarding Claim 2, Castillo teaches all of the limitations of Claim 1 (see above). Castillo further teaches the cell density is determined by electrical impedance analysis (page 6, lines 25-26)(the sensor system comprises the sensor for measuring impedance across at least a portion of the fixed bed). The sensor must measure the impedance across some portion of the fixed bed in order to be able to measure the impedance. Therefore, the limitations of Claim 2 are met. Regarding Claim 49, Castillo teaches all of the limitations of Claim 1 (see above). The portion of the fixed bed must be located in a common chamber with the fixed bed as it is a portion of the fixed bed. Therefore, Castillo teaches all of the limitations of Claim 49. Regarding Claim 54, Castillo teaches the following: A culture device with a fixed bed bioreactor (page 2, lines 23-24) (an apparatus for culturing cells comprising a bioreactor including a fixed bed for culturing cells); A sensor containing an electrode arrangement to measure culture parameters especially biomass (cell density)(page 6, lines 18-20)(a sensor system for sensing a cell density of at least a portion of the fixed bed); The cell density is determined by electrical impedance analysis (page 6, lines 25-26)(a sensor for measuring impedance across at least a portion of the fixed bed); The electrical impedance analysis is done using an electrode arrangement of at least four measuring electrodes (pair of electrodes)(page 6, lines 26-28) and as seen in Fig. 7, the sensor element containing the pair of electrodes that are arranged at different locations within the cell culture area and arranged with a portion of the fixed bed positioned between (page 27, lines 5-9). Note: Castillo teaches the particular features, structures or characteristics may be combined in any suitable manner in one or more embodiments. Regarding Claim 55, Castillo teaches all of the limitations of Claim 54 (see above). The portion of the fixed bed must be located in a common chamber with the fixed bed as it is a portion of the fixed bed. Therefore, Castillo teaches all of the limitations of Claim 55. Regarding claim 60, Castillo discloses the electrodes of the pair of electrodes are located on opposite sides of the fixed bed (see Fig 7). Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim(s) 59, 61 is/are rejected under 35 U.S.C. 103 as being unpatentable over CASTILLO (GB2465282) in view of MAIRESSE (CA3106661). Regarding claim 59, Castillo teaches all of the limitations of claim 55 (see above). Castillo does not explicitly teach the fixed bed to comprise a spiral bed. However, Mairesse teaches a fixed bed perfusion bioreactor (page 9, lines 34-38) that can contain sensors for monitoring different parameters including a cell density sensor (page 16, lines 34-38) in which each bed comprises a spiral bed (page 32, line 13). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the device of Castillo with the spiral bed as taught by Mairesse. One would have been motivated to make this modification as it would help retain the cells being grown (page 32, line 14). Further, it would have been an obvious selection for the purposes of growing cell culture in a fixed bed and a selection based on its suitability for its intended purpose has been held prima facie obvious. See MPEP 2144.07. Regarding claim 61, Castillo teaches all of the limitations of claim 1 (see above). Castillo further discloses the electrode may be in contact with the culture medium and preferably arranged in the cell culture zone, or integrated in the culture vessel e.g. on or in a cell culture substrate within the culture zone, or in other words in contact with a cell culture substrate present in the culture zone (page 6, lines 6-15), but does not explicitly disclose the fixed bed has layers with the electrode located between the layers. However, Mairesse teaches a fixed bed perfusion bioreactor (page 9, lines 34-38) that can contain sensors for monitoring different parameters including a cell density sensor (page 16, lines 34-38) in which each bed comprises a spiral material forming layers (page 32, line 13; Fig 5-5a). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the device of Castillo with the spiral layered bed as taught by Mairesse. One would have been motivated to make this modification as it would help retain the cells being grown (page 32, line 14) and provide a greater surface area for cellular attachment. Further, it would have been obvious to one of ordinary skill in the art when combining these prior art features to locate the electrodes arranged on or in a cell culture substrate taught by Castillo in between the layers as taught by Mairesse to accurately sense culture density throughout each layer of the spiral substrate to ensure uniform cell distribute or determine the effects of layer location on cellular density. Further, it would have been obvious to one having ordinary skill in the art place the electrodes between layers of the fixed bed, since it has been held that rearranging parts of an invention involved only routine skill in the art. MPEP 2144.04. Response to Arguments Applicant’s arguments, see page 3, filed 7/29/26, with respect to the rejection in view of Mairesse of claims 1, 2, 49 have been fully considered and are persuasive. The 102 a1 rejection of claims 1, 2, 49 over Mairesse has been withdrawn. Regarding Applicant’s arguments on page 4, that Castillo does not teach two electrodes forming a pair or the fixed bed portion between the pair as in amended claim 1, the examiner respectfully disagrees. Figure 7 of Castillo clearly depicts two (a pair of) sensor elements (electrodes) 11 located with at least a portion of the fixed bed positioned therebetween (portion right of the leftmost sensor 11 and/or portion left of the rightmost sensor 11). As discussed in the above rejection, Castillo meets all the positively recited limitations of the bioreactor system as claimed. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. See references on attached PTO892 that relate to layered fixed beds and are therefore considered relevant to the state of the art of applicant’s endeavor. Any inquiry concerning this communication or earlier communications from the examiner should be directed to DANIELLE B HENKEL whose telephone number is (571)270-5505. The examiner can normally be reached M-Th 11-7 EST, Alt. Fridays. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Michael Marcheschi can be reached at 571-272-1374. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /DANIELLE B HENKEL/Examiner, Art Unit 1799 /William H. Beisner/Primary Examiner, Art Unit 1799
Read full office action

Prosecution Timeline

Show 2 earlier events
Apr 03, 2026
Response Filed
Jun 12, 2026
Final Rejection mailed — §102, §103, §112
Jul 13, 2026
Interview Requested
Jul 23, 2026
Applicant Interview (Telephonic)
Jul 23, 2026
Examiner Interview Summary
Jul 29, 2026
Request for Continued Examination
Jul 31, 2026
Response after Non-Final Action
Sep 23, 2026
Non-Final Rejection mailed — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12781172
STERILE SENSOR INSERTION
4y 0m to grant Granted Nov 03, 2026
Patent 12774440
CELL CULTURE APPARATUS
4y 5m to grant Granted Oct 27, 2026
Patent 12774438
CASSETTE FOR STERILITY TESTING
3y 1m to grant Granted Oct 27, 2026
Patent 12767914
ADJUSTABLE FERMENTATION AND CELL CULTURE FLASKS WITH INTEGRATED ANALYTE SENSORS
5y 2m to grant Granted Oct 20, 2026
Patent 12767913
HYBRID ASEPTIC CONNECTION SYSTEM AND ASEPTIC CONNECTION METHOD FOR ANTIBODY PHARMACEUTICAL MANUFACTURING PROCESS
4y 1m to grant Granted Oct 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
56%
Grant Probability
80%
With Interview (+23.4%)
3y 8m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 653 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month